Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi‐mutated herpes simplex virus type‐1 (G207)

Overview of attention for article published in FASEB Journal, August 1999

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent: 10 patents

Readers on

mendeley: 39 Mendeley

So far, Altmetric has seen 10 patents that reference this research output.

COMPOSITIONS AND METHODS OF USING STAT1/3 INHIBITORS WITH ONCOLYTIC HERPES VIRUS

Application EP-4122478-A1

European Patent Office

25 Jan 2023

ONCOLYTIC VIRUS CARRYING E-CADHERIN AND USES THEREOF

Application WO-2019032866-A1

World Intellectual Property Organisation (WIPO)

14 Feb 2019

ONCOLYTIC HERPES SIMPLEX VIRUS VECTORS EXPRESSING IMMUNE SYSTEM-STIMULATORY MOLECULES

Application WO-2018026872-A1

World Intellectual Property Organisation (WIPO)

08 Feb 2018

HSV VECTORS WITH ENHANCED REPLICATION IN CANCER CELLS

Application WO-2017190112-A1

World Intellectual Property Organisation (WIPO)

02 Nov 2017

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 6 additional patents.